Description
Rofixim 200 mg Capsule is an oral antibiotic manufactured by Radiant Pharmaceuticals Ltd., containing cefixime trihydrate, a third-generation cephalosporin. It is used to treat a variety of bacterial infections, including urinary tract infections, respiratory tract infections, and typhoid fever. Cefixime works by inhibiting the synthesis of bacterial cell walls, leading to bacterial cell death. The usual adult dosage is 200–400 mg daily, either as a single dose or divided into two doses. For children aged 6 months or older, the dosage is typically 8 mg/kg/day. The treatment duration is generally 7 days, which may be extended to 14 days depending on the severity of the infection. Common side effects include diarrhea, abdominal pain, and nausea. It should be used with caution in patients with a history of gastrointestinal disease, particularly colitis, and in those with renal impairment. Rofixim 200 mg Capsule is contraindicated in patients with known hypersensitivity to cephalosporins.
 20MG.jpeg)
60 MG.jpeg)
 2GM.jpeg)
.jpeg)
 ..jpeg)
 25MG.jpeg)
 1GM.jpeg)
 ..jpeg)
 10MG.jpeg)
Change Language